Prevalence and Dynamic of Sleep-disordered Breathing in Patients Pre and Post Heart Transplantation

NCT03026634 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2021-05-06

No results posted yet for this study

Summary

Sleep-disordered breathing is believed to appear at a high prevalence in end-stage heart failure patients and the presence of sleep-disordered breathing has been associated with increased mortality. This study is designed to investigate prevalence and dynamics of sleep-disordered breathing in end-stage heart failure patients pre and post heart transplantation.

Conditions

  • Sleep Disordered Breathing Central
  • Heart Failure
  • Heart Transplantation

Interventions

BEHAVIORAL

Sleep-disordered breathing

Prevalence and dynamic of sleep-disordered breathing after heart transplantation

Sponsors & Collaborators

  • The German Heart Foundation

    collaborator OTHER
  • Deutsche Stiftung für Herzforschung

    collaborator OTHER
  • Heart and Diabetes Center North-Rhine Westfalia

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2020-10-09
Completion
2020-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03026634 on ClinicalTrials.gov